In humans, genetic variations of FKBP51 have been identified as a risk factor for the development of post-traumatic stress disorder (PTSD), enhanced recurrence of depressive disorders, and faster antidepressant treatment response [27–33]. Here, FKBP4 is linked to post-traumatic stress disorder.